Moon S, Kim J, Lee Y, Cho H, Choi Y, Yoon J
Exp Mol Med. 2025; .
PMID: 40082672
DOI: 10.1038/s12276-025-01419-y.
Kawaguchi H
J Bone Miner Metab. 2025; .
PMID: 39964554
DOI: 10.1007/s00774-025-01589-9.
An Z, Wang J, Li C, Tang C
Cell Commun Signal. 2025; 23(1):25.
PMID: 39806388
PMC: 11730785.
DOI: 10.1186/s12964-024-02005-x.
Abelha Pereira F, Miranda D, Alvarenga J, Correia A
Cureus. 2024; 16(11):e72889.
PMID: 39624554
PMC: 11611426.
DOI: 10.7759/cureus.72889.
Frara S, Acanfora M, Franzese V, Brandi M, Losa M, Giustina A
Pituitary. 2024; 27(6):813-823.
PMID: 39570564
DOI: 10.1007/s11102-024-01468-y.
[Osteoporosis-Definition, risk assessment, diagnosis, prevention and treatment (update 2024) : Guidelines of the Austrian Society for Bone and Mineral Research].
Dimai H, Muschitz C, Amrein K, Bauer R, Cejka D, Gasser R
Wien Klin Wochenschr. 2024; 136(Suppl 16):599-668.
PMID: 39356323
PMC: 11447007.
DOI: 10.1007/s00508-024-02441-2.
Vitamin D and hip protectors in osteosarcopenia: a combined hip fracture preventing approach.
Giustina A, Giustina A
Rev Endocr Metab Disord. 2024; 26(1):1-18.
PMID: 39352578
PMC: 11790758.
DOI: 10.1007/s11154-024-09907-8.
Comparison of the Clinical Efficacy of Anabolic Agents and Bisphosphonates in the Patients With Osteoporotic Vertebral Fracture: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Jeon I, Park S, Moon B, Choi M, Kuh S, Kim J
Neurospine. 2024; 21(2):416-429.
PMID: 38697911
PMC: 11224729.
DOI: 10.14245/ns.2347256.628.
Organic Matrices of Calcium Carbonate Biominerals Improve Osteoblastic Mineralization.
Nahle S, Lutet-Toti C, Namikawa Y, Piet M, Brion A, Peyroche S
Mar Biotechnol (NY). 2024; 26(3):539-549.
PMID: 38652191
DOI: 10.1007/s10126-024-10316-w.
CRIF1 attenuates doxorubicin-mediated mitochondrial dysfunction and myocardial senescence via regulating PXDN.
Zhou L, Zhai G, Tian G
Aging (Albany NY). 2024; 16(6):5567-5580.
PMID: 38517371
PMC: 11006484.
DOI: 10.18632/aging.205664.
Biomechanical analysis of alveolar bones with compromised quality supporting a 4-unit implant bridge; a possible association with implant-related sequestration (IRS).
Yoon Y, Kang I, Noh G, Kwon Y
Clin Oral Investig. 2024; 28(3):197.
PMID: 38448748
DOI: 10.1007/s00784-024-05589-3.
Severe Osteoporosis With Pathogenic Variant.
Stringer F, Sims N, Sachithanandan N, Aleksova J
JCEM Case Rep. 2024; 2(3):luae021.
PMID: 38404691
PMC: 10888517.
DOI: 10.1210/jcemcr/luae021.
Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia/Osteoporosis.
Yun S, Sang H, Park S, Chin S
Int J Mol Sci. 2024; 25(3).
PMID: 38338751
PMC: 10855748.
DOI: 10.3390/ijms25031474.
Acromegaly and Bone: An Update.
Giustina A
Endocrinol Metab (Seoul). 2024; 38(6):655-666.
PMID: 38164073
PMC: 10764988.
DOI: 10.3803/EnM.2023.601.
Differential Effects of PTH (1-34), PTHrP (1-36), and Abaloparatide on the Murine Osteoblast Transcriptome.
Mosca M, He Z, Ricarte F, Le Henaff C, Partridge N
J Endocr Soc. 2023; 8(1):bvad156.
PMID: 38155918
PMC: 10753291.
DOI: 10.1210/jendso/bvad156.
High prevalence of vertebral fractures associated with preoperative cortisol levels in patients with recent diagnosis of Cushing disease.
Sun H, Wu C, Hu B, Xie G
Ann Med. 2023; 55(2):2282183.
PMID: 37983536
PMC: 10836264.
DOI: 10.1080/07853890.2023.2282183.
Age, body composition parameters and glycaemic control contribute to trabecular bone score deterioration in acromegaly more than disease activity.
Sagova I, Mokan M, Tonhajzerova I, Roncakova M, Vanuga P
Front Endocrinol (Lausanne). 2023; 14:1197725.
PMID: 37670889
PMC: 10475557.
DOI: 10.3389/fendo.2023.1197725.
Astaxanthin as a Potent Antioxidant for Promoting Bone Health: An Up-to-Date Review.
Davan I, Fakurazi S, Alias E, Ibrahim N, Hwei N, Hassan H
Antioxidants (Basel). 2023; 12(7).
PMID: 37508018
PMC: 10376010.
DOI: 10.3390/antiox12071480.
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?.
Pofi R, Caratti G, Ray D, Tomlinson J
Endocr Rev. 2023; 44(6):975-1011.
PMID: 37253115
PMC: 10638606.
DOI: 10.1210/endrev/bnad016.
NMP4, an Arbiter of Bone Cell Secretory Capacity and Regulator of Skeletal Response to PTH Therapy.
Korff C, Atkinson E, Adaway M, Klunk A, Wek R, Vashishth D
Calcif Tissue Int. 2023; 113(1):110-125.
PMID: 37147466
PMC: 10330242.
DOI: 10.1007/s00223-023-01088-x.
